CME Group Inc. $CME Shares Acquired by Envestnet Asset Management Inc.

Envestnet Asset Management Inc. raised its stake in shares of CME Group Inc. (NASDAQ:CME) by 2.6% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 584,815 shares of the financial services provider’s stock after purchasing an additional 14,609 shares during the quarter. Envestnet Asset Management Inc.’s holdings in CME Group were worth $161,187,000 at the end of the most recent reporting period.

A number of other hedge funds have also bought and sold shares of the stock. Great Lakes Advisors LLC increased its stake in CME Group by 2.3% during the 1st quarter. Great Lakes Advisors LLC now owns 1,661 shares of the financial services provider’s stock valued at $441,000 after purchasing an additional 37 shares in the last quarter. Beaumont Financial Advisors LLC increased its stake in CME Group by 2.0% during the 2nd quarter. Beaumont Financial Advisors LLC now owns 1,952 shares of the financial services provider’s stock valued at $538,000 after purchasing an additional 38 shares in the last quarter. Whittier Trust Co. of Nevada Inc. increased its stake in CME Group by 0.8% during the 2nd quarter. Whittier Trust Co. of Nevada Inc. now owns 5,021 shares of the financial services provider’s stock valued at $1,384,000 after purchasing an additional 38 shares in the last quarter. Trifecta Capital Advisors LLC increased its stake in CME Group by 59.2% during the 2nd quarter. Trifecta Capital Advisors LLC now owns 113 shares of the financial services provider’s stock valued at $31,000 after purchasing an additional 42 shares in the last quarter. Finally, OneAscent Financial Services LLC increased its stake in CME Group by 4.0% during the 1st quarter. OneAscent Financial Services LLC now owns 1,106 shares of the financial services provider’s stock valued at $293,000 after purchasing an additional 43 shares in the last quarter. Institutional investors and hedge funds own 87.75% of the company’s stock.

CME Group Stock Down 1.8%

CME stock opened at $266.33 on Wednesday. The firm has a market cap of $95.98 billion, a PE ratio of 25.81, a P/E/G ratio of 4.58 and a beta of 0.41. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. The firm’s fifty day moving average is $266.38 and its 200 day moving average is $272.08. CME Group Inc. has a one year low of $213.94 and a one year high of $290.79.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, October 22nd. The financial services provider reported $2.68 EPS for the quarter, beating the consensus estimate of $2.63 by $0.05. The company had revenue of $1.54 billion for the quarter, compared to analyst estimates of $1.56 billion. CME Group had a net margin of 58.84% and a return on equity of 14.61%. The firm’s revenue was down 3.0% on a year-over-year basis. During the same quarter last year, the business earned $2.68 earnings per share. On average, research analysts forecast that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were issued a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.9%. The ex-dividend date of this dividend was Tuesday, September 9th. CME Group’s dividend payout ratio (DPR) is presently 48.45%.

Analysts Set New Price Targets

A number of research analysts have issued reports on the stock. Barclays cut their price target on shares of CME Group from $298.00 to $280.00 and set an “equal weight” rating on the stock in a research note on Wednesday, October 8th. Raymond James Financial cut their price objective on shares of CME Group from $309.00 to $307.00 and set an “outperform” rating on the stock in a research note on Monday, October 13th. Morgan Stanley increased their price objective on shares of CME Group from $312.00 to $314.00 and gave the stock an “overweight” rating in a research note on Thursday, October 23rd. Jefferies Financial Group cut their price objective on shares of CME Group from $313.00 to $304.00 and set a “buy” rating on the stock in a research note on Friday, October 10th. Finally, Wall Street Zen lowered shares of CME Group from a “hold” rating to a “sell” rating in a research note on Sunday, July 13th. Eight analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have issued a Sell rating to the company’s stock. According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $284.53.

Insider Activity at CME Group

In other CME Group news, General Counsel Jonathan L. Marcus sold 392 shares of the stock in a transaction on Thursday, September 18th. The shares were sold at an average price of $262.00, for a total transaction of $102,704.00. Following the transaction, the general counsel directly owned 7,851 shares of the company’s stock, valued at $2,056,962. This trade represents a 4.76% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Sunil Cutinho sold 11,896 shares of the stock in a transaction on Tuesday, August 26th. The shares were sold at an average price of $271.47, for a total transaction of $3,229,407.12. Following the transaction, the insider directly owned 17,440 shares in the company, valued at approximately $4,734,436.80. The trade was a 40.55% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. In the last three months, insiders sold 13,043 shares of company stock valued at $3,527,956. 0.30% of the stock is currently owned by company insiders.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.